Synthesis of 8-bromo-5,12-tetracenequinone and 2-bromotetracene derivatives
145
5.16 mmol), and DMF (5 mL) were used and the product was recrystallized from
THF–hexane. Compound 1b was obtained as a yellow solid (171 mg, 39 %): mp
-
1
2
1
1
1
56–258 °C; IR (cm ) 3,067, 2,957, 2,928, 2,870, 1,672, 1,597, 1,452, 1,398,
1
,314, 1,296, 1,184, 1,063, 997, 930, 806, 739; H NMR (500 MHz, CDCl ) d
.04–1.07 (m, 6H), 1.71–1.75 (m, 4H), 2.76–2.79 (m, 4H), 7.76 (d, J = 8.8 Hz,
H), 7.97 (d, J = 8.8 Hz, 1H), 8.16 (s, 2H), 8.27 (s, 1H), 8.74 (s, 1H), 8.81 (s, 1H);
3
1
3
C NMR (126 MHz, CDCl ) d 14.2, 23.9, 35.0, 123.8, 128.1, 129.1, 130.3, 130.9,
3
?
31.4, 132.0, 132.1, 132.7, 133.4, 136.0, 148.2, 148.2, 182.8; MS m/z 420 (M , 99),
1
4
5
?
22 (M , 100); Anal. Calcd. for C H BrO : C, 68.42, H, 5.02; found: C, 68.57, H,
.27.
2
4
21
2
Synthesis of 2-bromo-8,9-dipropyltetracene 2b
This compound was synthesized following the same procedure as for 2a except that
reagents 1b (190 mg, 0.45 mmol), Al(O-s-Bu) (1.12 g, 4.54 mmol), and cyclo-
3
hexanol (10 mL) were used and the product was recrystallized from THF–hexane.
Compound 2b was obtained as an orange solid (29 mg, 17 %). The bromotetracene
2
b in solution was slightly unstable when exposed to light and air, and therefore it
-
1
required handling in the dark: Decomp. 270 °C; IR (cm ) 3,005, 2,955, 2,930,
2
1
,870, 1,636, 1,605, 1,464, 1,458, 1,381, 1,296, 1,121, 1,044, 910, 895, 790; H
NMR (500 MHz, CDCl ) d 1.07–1.10 (m, 6H), 1.56–1.80 (m, 4H), 2.77–2.80 (m,
3
4
H), 7.39 (d, J = 9.1 Hz, 1H), 7.75 (s, 2H), 7.85 (d, J = 9.1 Hz, 1H), 8.15 (s, 1H),
?
.51 (s, 1H), 8.53 (s, 1H), 8.54 (s, 1H), 8.58 (s, 1H); MS m/z 390 (M , 100), 392
8
?
M , 99); Anal. Calcd. for C H Br: C, 73.66, H, 5.92; found: C, 73.84, H, 6.09.
(
2
4 23
Synthesis of 8-bromo-2,3-dihexyl-5,12-tetracenequinone 1c
This compound was synthesized following the same procedure as for 1a except
that reagents 4 (175 mg, 0.51 mmol), 6c (166 mg, 0.51 mmol), NaI (386 mg,
2
.57 mmol), and DMF (3 mL) were used and the product was recrystallized from
THF–hexane. Compound 1c was obtained as a yellow solid (20 mg, 8 %): mp
-
1
2
1
6
37–238 °C; IR (cm ) 3,067, 2,955, 2,924, 2,855, 1,672, 1,597, 1,455, 1,402,
1
,312, 1,298, 1,184, 1,065, 943, 739; H NMR (500 MHz, CDCl ) d 0.90–0.93 (m,
3
H), 1.34–1.44 (m, 12H), 1.65–1.71 (m, 4H), 2.76–2.80 (m, 4H), 7.75 (d,
J = 8.7 Hz, 1H), 7.96 (d, J = 8.8 Hz, 1H), 8.15 (s, 2H), 8.26 (s, 1H), 8.73 (s, 1H),
1
3
8
1
1
.80 (s, 1H); C NMR (126 MHz, CDCl ) d 14.1, 22.6, 29.4, 30.8, 31.7, 33.0,
3
23.8, 128.1, 129.2, 130.4, 130.9, 131.5, 132.0, 132.1, 132.7, 133.4, 136.0, 148.5,
?
48.5, 182.9; MS m/z 421 (100), 504 (M , 34), 506 (M , 42); Anal. Calcd. for
?
C H BrO : C, 71.04, H, 6.69; found: C, 71.28, H, 6.58.
2
3
0
33
Synthesis of 2,3-dipropyl-8-trimethylsilylethynyl-5,12-tetracenequinone 8b
To a degassed THF solution (15 mL) of 1b (106 mg, 0.25 mmol), trimethylsilyl-
acetylene (0.2 mL, 1.42 mmol), CuI (8 mg, 0.058 mmol), and i-Pr NH (2 mL),
2
PdCl (PPh ) (9 mg, 0.026 mmol) was added. The reaction mixture was stirred
2
3 2
at 50 °C for 16 h. After cooling to room temperature and then evaporating
123